As part of a genetic analysis of the biogenesis and function of the vacuole (lysosome) in the yeast Saccharomyces cerevisiae, assays of vacuolar pH were developed and used to identify mutants defective in vacuolar acidification.Vacuoles were labeled with 6-carboxyfluorescein with the membrane-permeant precursor 6-carboxyfluorescein diacetate. Dual-excitation flow cytometry was used to calibrate the pH-dependence of 6-carboxyfluorescein fluorescence in vivo.Vacuoles in wild-type yeast were mildly acidic, pH 6.2, in cells grown under several different conditions. Cultures labeled with 6-carboxyfluorescein were screened by fluorescence-ratio microscopy to detect mutants that had defects related to vacuolar acidification. A recessive nuclear mutation, vphl-1, caused an abnormally high vacuolar pH of 6.9, as assayed by flow cytometry, and eliminated vacuolar uptake of the weak base quinacrine. Acidification in a pepl2::LEU2 mutant appeared defective by fluorescence-ratio microscopy and qulnacrineuptake assays, but the vacuolar pH in thepepl2::LEU2 mutant was nearly normal (pH 6.3) in flow cytometric assays.Vacuoles in Saccharomyces cerevisiae are analogous to lysosomes of other organisms. Both types of organelles contain similar sets of proteases and other hydrolytic enzymes (1, 2), and both are energized and acidified by similar membrane-bound, proton-translocating ATPases (H+-ATPase) (3-6). Vacuolar proteases are required for intracellular protein turnover induced by nitrogen starvation (7). Apart from that typically "lysosomal" activity, a variety of additional functions have been ascribed to the vacuole, including maintenance of cytosolic amino acid homeostasis (8, 9), regulation of cellular calcium metabolism (8, 10), and others (11). Genetic analysis of protease-deficient mutants has been instrumental in delimiting the physiological significance of the vacuolar proteases (7 METHODSStrains and Culture Conditions. The wild-type strain was the diploid formed by mating strains X2180-1A and X2180-1B. Mutant strains and genotypes were BJ4895, a/a vphl-J/ vphl-1 trpl/+ leu2/+ +/ura3-52 and BJ4984, a/a pepl2:: LEU2/pepl2::LEU2 ura3-52/ura3-52 leu2-1/leu2-1 hisl1+ ade6/+. Growth media YPD and SC have been described (12). Cells in the logarithmic-growth phase were prepared by overnight growth in YPD or SC (10 ml) at 30'C in roller tube cultures. Culture densities were maintained below 2 x 107 cell per ml by dilution with YPD or SC as required.Labeling with Fluorescent Dyes. Medium for labeling with 6-CF diacetate (6-CFDA; C1362; Molecular Probes) was prepared by adding 50 mM citric acid to YPD, adjusting the pH to 3.0 with 12 M HCl, autoclaving, and then filtering (0.2 gm membrane filter); 6-CFDA was added to the medium immediately before use by dilution from 5 mM stock solutions in dimethyl sulfoxide; unless otherwise noted, the final 6-CFDA concentration was 5 1LM. Logarithmic-phase cells were harvested by membrane filtration, resuspended at 2 X 107 cell per ml in the labeling medium, and incubated with shakin...

No abstract

No abstract

To produce concentrations of zidovudine (AZT) in plasma and cerebrospinal fluid that would provide constant inhibition of the replication of human immunodeficiency virus (HIV), we gave AZT by continuous intravenous infusion to 21 children ranging in age from 14 months to 12 years who had acquired HIV infection through transfusions or perinatally. All patients were symptomatic before AZT treatment (Class P2 of the Centers for Disease Control); 13 (62 percent) had evidence of neurodevelopmental abnormalities. The mean CD4/CD8 ratio was 0.18; 11 patients had CD4 counts below 0.2 x 10(9) per liter. We administered AZT at four dose levels: 0.5, 0.9, 1.4, and 1.8 mg per kilogram of body weight per hour. The plasma drug concentrations achieved at the respective dose levels were 1.9 +/- 0.3, 2.8 +/- 1.4, 3.1 +/- 1.1, and 4.5 +/- 1.0 microM. The steady-state cerebrospinal fluid:plasma ratio was 0.24 +/- 0.07. The only evidence of toxicity was bone marrow suppression. Transfusion was required in 14 patients because of low levels of hemoglobin (5 mmol per liter [less than 8 g per deciliter]). Dose-limiting neutropenia (less than 0.5 x 10(9) polymorphonuclear leukocytes per cubic millimeter) occurred in most patients who received doses of 1.4 mg per kilogram per hour or more. Improvement in neurodevelopmental abnormalities occurred in all 13 children who had presented with encephalopathy before treatment. Serial measurements of IQ before therapy and after three and six months of continuous therapy with AZT showed that IQ scores, including those for verbal and performance IQ, rose in these 13 patients and in 5 other children who had no detectable evidence of encephalopathy before treatment. Most patients also had increased appetite and weight, decreased lymphadenopathy and hepatosplenomegaly, decreased immunoglobulin levels, and increased numbers of CD4 cells. In some patients the improvement in the features of encephalopathy occurred despite the absence of immunologic improvement. We conclude that AZT is beneficial in children with symptomatic HIV infection, especially those with encephalopathy (which may be subclinical), and that the optimal continuous intravenous dose of AZT in children is between 0.9 and 1.4 mg per kilogram per hour.

Abstract. Concurrent with Riezman's report (Riezman, H. 1985, Cell. 40:1001-1009) that fluid-phase endocytosis of the small molecule Lucifer yellow occurs in the yeast Saccharomyces cerevisiae, Makarow (Makarow, M. 1985. EMBO [Eur. Mol. Biol. Organ.] J. 4:1861-1866) reported the endocytotic uptake of 70-kD FITC-dextran (FD) and its subsequent compartmentation into the yeast vacuole. Samples of FD synthesized and purified here failed to label yeast vacuoles under conditions that allowed labeling using commercial FD. Chromatography revealed that the commercial FD was heavily contaminated with at least three low molecular weight fluorescent compounds. Dialysis was ineffective for removing the contaminants.After purification (Sephadex G25, ethanol extraction), commercial FD was incapable of labeling vacuoles. Extracts of cells labeled with partially purified FD contained FITC, not FD, based on Sephadex and thin layer chromatography. In either the presence or absence of unlabeled 70-kD dextran, authentic FITC (10 ~tg/ml) was an effective labeling agent for vacuoles. The rapid kinetics (0.28 pmol/min per 106 cells at pH 5.5) and the pH dependence of FITC uptake suggest that the mechanism of FITC uptake involves diffusion rather than endocytosis. In view of these results, labeling experiments that use unpurified commercial FD should be interpreted with caution. SEVERAL lines of evidence suggest that uptake of the small molecule, Lucifer yellow (Riezman, 1985), and macromolecules (Makarow, 1985;Makarow and Nevalainen, 1987) can occur in the yeast Saccharomyces cerevisiae by a mechanism that resembles fluid-phase endocytosis. In a potentially related development, recent reports strongly support a role for receptor-mediated endocytosis in the yeast cell's response to a-factor mating pheromone (Jenness and Spatrick, 1986;Chvatchko et al., 1986). Fluidphase endocytosis should provide a port-of-entry for loading cells with a variety of otherwise impermeant metabolites or tracer molecules. Its occurrence in yeast encourages the application of the powerful genetics of this organism not only for the analysis of endocytotic mechanisms but also for the analysis of phenomena dependent on internalization of impermeant substances.In the latter of these applications, we have attempted to replicate the reported labeling of yeast vacuoles by high molecular weight, FITC-conjugated dextran (FD) t to investigate problems in organelle biogenesis and function (Makarow, 1985;Makarow and Nevalainen, 1987). As will be reported here, we found that the fluorescent staining of yeast vacuoles by "70-kD FD" results from the uptake of low molecular weight impurities in commercial samples of FD. FITC appears to be the most potent of these impurities, and its uptake most likely reflects simple diffusion and trapping rather than endocytosis.Our results suggest that attempts to introduce macromolecular materials into whole yeast cells by an endocytotic route may be ill-advised. Also, in view of the potential reactivity of FITC (particularly if concen...